Today NVAX ranks # as SELL CANDIDATE.
Today NVAX ranks # as SELL CANDIDATE.

NVAX stock Novavax

NVAX stock
Novavax

February 15, 2019
Change -3.18%
Chart period: 2018-11-16 - 2019-02-15
VOLUME
Buy
TREND
Buy

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

Will NVAX stock price go up or down on Tue, 19 Feb 2019?

Novavax Forecast and Stock Analysis

Technical NVAX stock analysis for February 15, 2019.

Sell candidate since 2019-02-15
Shorts n/a
Cash n/a
Loans n/a
Beta 2.31
ROA -63.73

Novavax fell by -3.18% in the last day from $2.20 to $2.13 The price has fallen in 5 of the last 10 days and is down by -7.39% for this period. Volume has increased in the last day by 1.54 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 9.27 million shares bought and sold for approximately $19.74 million.

Close price at the end of the last trading day (Friday, 15th Feb 2019) of the NVAX stock was $2.13. This is 3.18% less than the trading day before Thursday, 14th Feb 2019.

During day the stock fluctuated 4.25% from a day low at $2.12 to a day high of $2.21.

30 day high of the NVAX stock price was $2.44 and low was $2.00.
90 day high was $2.58 and low was $1.63.
52 week high for the Novavax - $2.75 and low - $1.15.

Trend

Novavax lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.69% during the next 3 months and, with 90% probability hold a price between $2.23 and $3.14 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Novavax holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $2.20 and $2.15. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday January 31, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 49 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Novavax finds support from accumulated volume at $2.05.

Support: $2.05 Price: $2.13 Resistance: $2.14

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.09 between high and low, or 4.25%. For the last week, the stock has had a daily average volatility of 3.88%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation: Sell Candidate

The Novavax stock holds several negative signals and despite the positive trend we believe Novavax will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.

Today NVAX ranks # as SELL CANDIDATE.
Today NVAX ranks # as SELL CANDIDATE.